相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。hsa-mir183/EGR1-mediated regulation of E2F1 is required for CML stem/progenitor cell survival
Francesca Pellicano et al.
BLOOD (2018)
Modeling and antitumor studies of a modified L–penetratin peptide targeting E2F in lung cancer and prostate cancer
Tazeem Shaik et al.
Oncotarget (2018)
DNA repair pathways and cisplatin resistance: an intimate relationship
Clarissa Ribeiro Reily Rocha et al.
CLINICS (2018)
A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts
Xiaoqi Xie et al.
ONCOTARGET (2014)
Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer
Xiaoqi Xie et al.
CANCER BIOLOGY & THERAPY (2013)
E2F1 apoptosis counterattacked: evil strikes back
Brigitte M. Puetzer et al.
TRENDS IN MOLECULAR MEDICINE (2013)
The Dark Side of E2F1: In Transit beyond Apoptosis
David Engelmann et al.
CANCER RESEARCH (2012)
Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer
K. Takezawa et al.
BRITISH JOURNAL OF CANCER (2011)
Thymidylate synthase inhibitors for non-small cell lung cancer
Elena Galvani et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Conserved RB functions in development and tumor suppression
Gabriel M. Gordon et al.
PROTEIN & CELL (2011)
Mirror image phage display-a method to generate D-peptide ligands for use in diagnostic or therapeutical applications
Susanne Aileen Funke et al.
MOLECULAR BIOSYSTEMS (2009)
Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug
Olga B. Garbuzenko et al.
PHARMACEUTICAL RESEARCH (2009)
Atypical E2Fs: new players in the E2F transcription factor family
Tim Lammens et al.
TRENDS IN CELL BIOLOGY (2009)
Emerging roles of E2Fs in cancer: an exit from cell cycle control
Hui-Zi Chen et al.
NATURE REVIEWS CANCER (2009)
An E2F1-dependent gene expression program that determines the balance between proliferation and cell death
Timothy C. Hallstrom et al.
CANCER CELL (2008)
E2F1 in gliomas: A paradigm of oncogene addiction
Marta M. Alonso et al.
CANCER LETTERS (2008)
Tailoring to RB: tumour suppressor status and therapeutic response
Erik S. Knudsen et al.
NATURE REVIEWS CANCER (2008)
Overexpression of E2F1 in lung and liver metastases of human colon cancer is associated with gene amplification
M Iwamoto et al.
CANCER BIOLOGY & THERAPY (2004)
The emerging role of E2F-1 in the DNA damage response and checkpoint control
C Stevens et al.
DNA REPAIR (2004)
E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1
S Taubert et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas
VG Gorgoulis et al.
JOURNAL OF PATHOLOGY (2002)
E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints
B Ren et al.
GENES & DEVELOPMENT (2002)
The E2F1-3 transcription factors are essential for cellular proliferation
LZ Wu et al.
NATURE (2001)
The Rb/E2F pathway and cancer
JR Nevins
HUMAN MOLECULAR GENETICS (2001)
Rb function in cell-cycle regulation and apoptosis
JW Harbour et al.
NATURE CELL BIOLOGY (2000)
分享论文
